We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RYGB Patients Face Higher Risk of Additional Operations

By HospiMedica International staff writers
Posted on 02 Jan 2020
A new study suggests that patients undergoing vertical sleeve gastrectomy (VSG) have a lower risk of subsequent operative intervention than those undergoing Roux-en-Y gastric bypass (RYGB).

Researchers at Harvard Medical School (HMS; Boston, MA, USA), Wake Forest School of Medicine (Winston-Salem, NC, USA), and other institutions used data from a U.S. More...
national insurance claims database of adults who underwent a first RYGB or VSG procedure between January 1, 2010, and June 30, 2017. The final weighted matched sample included 4,476 patients undergoing RYGB and 8,551 patients undergoing VSG, with the primary outcome being any abdominal operative intervention after the index procedure. Secondary outcomes included biliary procedures, abdominal wall hernia repair, bariatric conversion or revision, other abdominal operations, and endoscopy and enteral access.

The results revealed that in patients followed up for up to four years after surgery, those undergoing VSG were less likely to have any subsequent operative intervention than matched patients undergoing RYGB. They were similarly less likely to undergo biliary procedures, abdominal wall hernia repair, other abdominal operations, and endoscopy or enteral access placed. The patients undergoing VSG were also more likely to undergo bariatric conversion or revision. The study was published on December 18, 2019, in JAMA Network Open.

“Patients undergoing VSG appeared to be less likely than matched patients undergoing RYGB to experience subsequent abdominal operative interventions, except for bariatric conversion or revision procedures,” concluded senior author James Wharam, BCh, MPH, of HMS, and colleagues. “Patients considering bariatric surgery should be aware of the increased risk of subsequent procedures associated with RYGB. It's important for patients to understand not only the many benefits of bariatric surgery, but also the risks, including the possible need for more surgery down the road.”

VSG is a restrictive form of weight loss surgery intended for the morbidly obese which reduces the size of the stomach by removing the lateral 2/3 of the stomach with a stapling device. While the stomach is drastically reduced in size, function is preserved, with no malabsorption of nutrients and supplements. The procedure avoids problems associated with bypass forms of weight loss surgery, including anemia, intestinal obstruction or blockage, osteoporosis, and protein and vitamin deficiency, and since about 100-200 ml of stomach capacity is maintained, there are very few restrictions on food consumption.

Related Links:
Harvard Medical School
Wake Forest School of Medicine



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.